REFERENCES
1. Daniel N, Lécuyer E, Chassaing B. Host/microbiota interactions in health and diseases-time for mucosal microbiology! Mucosal Immunol. 2021;14:1006-16.
2. Hou K, Wu ZX, Chen XY, et al. Microbiota in health and diseases. Signal Transduct Target Ther. 2022;7:135.
3. Daschner PJ, Grisham MB, Espey MG. Redox relationships in gut-microbiome interactions. Free Radic Biol Med. 2017;105:1-2.
4. Fava F, Rizzetto L, Tuohy KM. Gut microbiota and health: connecting actors across the metabolic system. Proc Nutr Soc. 2019;78:177-88.
5. Jensen BAH, Heyndrickx M, Jonkers D, et al. Small intestine vs. colon ecology and physiology: Why it matters in probiotic administration. Cell Rep Med. 2023;4:101190.
6. Filardy AA, Ferreira JRM, Rezende RM, Kelsall BL, Oliveira RP. The intestinal microenvironment shapes macrophage and dendritic cell identity and function. Immunol Lett. 2023;253:41-53.
7. Fassarella M, Blaak EE, Penders J, Nauta A, Smidt H, Zoetendal EG. Gut microbiome stability and resilience: elucidating the response to perturbations in order to modulate gut health. Gut. 2021;70:595-605.
8. Binda S, Hill C, Johansen E, et al. Criteria to qualify microorganisms as “Probiotic” in foods and dietary supplements. Front Microbiol. 2020;11:1662.
9. Sanders ME, Benson A, Lebeer S, Merenstein DJ, Klaenhammer TR. Shared mechanisms among probiotic taxa: implications for general probiotic claims. Curr Opin Biotechnol. 2018;49:207-16.
10. Hill C, Guarner F, Reid G, et al. Expert consensus document. The international scientific association for probiotics and prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11:506-14.
12. Ma T, Shen X, Shi X, et al. Targeting gut microbiota and metabolism as the major probiotic mechanism - an evidence-based review. Trends Food Sci Technol. 2023;138:178-98.
14. Cristofori F, Dargenio VN, Dargenio C, Miniello VL, Barone M, Francavilla R. Anti-inflammatory and immunomodulatory effects of probiotics in gut inflammation: a door to the body. Front Immunol. 2021;12:578386.
15. Singh A, Mazumder A, Das S, Kanda A, Tyagi PK, Chaitanya MVNL. Harnessing the power of probiotics: boosting immunity and safeguarding against various diseases and infections. Recent Adv Antiinfect Drug Discov. 2025;20:5-29.
16. Rwubuzizi R, Kim H, Holzapfel WH, Todorov SD. Beneficial, safety, and antioxidant properties of lactic acid bacteria: a next step in their evaluation as potential probiotics. Heliyon. 2023;9:e15610.
17. Aghamohammad S, Rohani M. Antibiotic resistance and the alternatives to conventional antibiotics: the role of probiotics and microbiota in combating antimicrobial resistance. Microbiol Res. 2023;267:127275.
18. Beglari S, Rezaie N, Jouriani FH, Khiavi EHAG, Aghamohammad S, Rohani M. Novel native probiotics with protective effects against nickel-induced kidney injury: a strategy for heavy metal toxicity. Biometals. 2025;38:863-71.
19. Petrariu OA, Barbu IC, Niculescu AG, et al. Role of probiotics in managing various human diseases, from oral pathology to cancer and gastrointestinal diseases. Front Microbiol. 2023;14:1296447.
20. Marco ML, Heeney D, Binda S, et al. Health benefits of fermented foods: microbiota and beyond. Curr Opin Biotechnol. 2017;44:94-102.
21. Foligné B, Daniel C, Pot B. Probiotics from research to market: the possibilities, risks and challenges. Curr Opin Microbiol. 2013;16:284-92.
22. Kumari M, Singh P, Nataraj BH, et al. Fostering next-generation probiotics in human gut by targeted dietary modulation: an emerging perspective. Food Res Int. 2021;150:110716.
23. Zhang H, Duan Y, Cai F, et al. Next-generation probiotics: microflora intervention to human diseases. Biomed Res Int. 2022;2022:5633403.
24. Fentie EG, Lim K, Jeong M, Shin JH. A comprehensive review of the characterization, host interactions, and stabilization advancements on probiotics: Addressing the challenges in functional food diversification. Compr Rev Food Sci Food Saf. 2024;23:e13424.
25. Yang SY, Han SM, Lee JY, Kim KS, Lee JE, Lee DW. Advancing gut microbiome research: the shift from metagenomics to multi-omics and future perspectives. J Microbiol Biotechnol. 2025;35:e2412001.
26. Galanis A, Papadimitriou K, Moloney GM. Editorial: omics technologies and bioinformatic tools in probiotic research. Front Microbiol. 2025;16:1577852.
27. Pearce SC, Coia HG, Karl JP, Pantoja-Feliciano IG, Zachos NC, Racicot K. Intestinal in vitro and ex vivo models to study host-microbiome interactions and acute stressors. Front Physiol. 2018;9:1584.
28. Berkhout M, Zoetendal E, Plugge C, Belzer C. Use of synthetic communities to study microbial ecology of the gut. Microbiome Res Rep. 2022;1:4.
29. Jans M, Vereecke L. A guide to germ-free and gnotobiotic mouse technology to study health and disease. FEBS J. 2025;292:1228-51.
30. Cheng AG, Ho PY, Aranda-Díaz A, et al. Design, construction, and in vivo augmentation of a complex gut microbiome. Cell. 2022;185:3617-3636.e19.
31. Whelan K, Alexander M, Gaiani C, et al. Design and reporting of prebiotic and probiotic clinical trials in the context of diet and the gut microbiome. Nat Microbiol. 2024;9:2785-94.
32. Daniel C, Poiret S, Dennin V, et al. Dual-color bioluminescence imaging for simultaneous monitoring of the intestinal persistence of lactobacillus plantarum and lactococcus lactis in living mice. Appl Environ Microbiol. 2015;81:5344-9.
33. Salomé-Desnoulez S, Poiret S, Foligné B, et al. Persistence and dynamics of fluorescent lactobacillus plantarum in the healthy versus inflamed gut. Gut Microbes. 2021;13:1-16.
34. Cornuault JK, Byatt G, Paquet ME, De Koninck P, Moineau S. Zebrafish: a big fish in the study of the gut microbiota. Curr Opin Biotechnol. 2022;73:308-13.
36. McMullen JG 2nd, Peters-Schulze G, Cai J, Patterson AD, Douglas AE. How gut microbiome interactions affect nutritional traits of Drosophila melanogaster. J Exp Biol. 2020:223.
37. Grenier T, Leulier F. How commensal microbes shape the physiology of Drosophila melanogaster. Curr Opin Insect Sci. 2020;41:92-9.
38. Chen D, Guo J, Li A, et al. Metabolic fluorine labeling and hotspot imaging of dynamic gut microbiota in mice. Sci Adv. 2023;9:eabg6808.
39. Apostolos AJ, Chordia MD, Kolli SH, Dalesandro BE, Rutkowski MR, Pires MM. Real-time non-invasive fluorescence imaging of gut commensal bacteria to detect dynamic changes in the microbiome of live mice. Cell Chem Biol. ;2022:1721-1728.e5.
40. Campisciano G, Biffi S. Microbiota in vivo imaging approaches to study host-microbe interactions in preclinical and clinical setting. Heliyon. 2022;8:e12511.
42. Basic M, Dardevet D, Abuja PM, et al. Approaches to discern if microbiome associations reflect causation in metabolic and immune disorders. Gut Microbes. 2022;14:2107386.
43. Kriaa A, Mariaule V, De Rudder C, et al. From animal models to gut-on-chip: the challenging journey to capture inter-individual variability in chronic digestive disorders. Gut Microbes. 2024;16:2333434.
44. Leung CM, de Haan P, Ronaldson-bouchard K, et al. A guide to the organ-on-a-chip. Nat Rev Methods Primers. 2022;2:118.
45. Alonso-Roman R, Mosig AS, Figge MT, et al. Organ-on-chip models for infectious disease research. Nat Microbiol. 2024;9:891-904.
46. Özkan A, LoGrande NT, Feitor JF, Goyal G, Ingber DE. Intestinal organ chips for disease modelling and personalized medicine. Nat Rev Gastroenterol Hepatol. 2024;21:751-73.
47. Grassart A, Malardé V, Gobaa S, et al. Bioengineered human organ-on-chip reveals intestinal microenvironment and mechanical forces impacting shigella infection. Cell Host Microbe. 2019;26:435-444.e4.
48. Boquet-Pujadas A, Feaugas T, Petracchini A, et al. 4D live imaging and computational modeling of a functional gut-on-a-chip evaluate how peristalsis facilitates enteric pathogen invasion. Sci Adv. 2022;8:eabo5767.
49. Kim HJ, Ingber DE. Gut-on-a-Chip microenvironment induces human intestinal cells to undergo villus differentiation. Integr Biol (Camb). 2013;5:1130-40.
50. Kim HJ, Huh D, Hamilton G, Ingber DE. Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow. Lab Chip. 2012;12:2165-74.
51. Verhulsel M, Simon A, Bernheim-Dennery M, et al. Developing an advanced gut on chip model enabling the study of epithelial cell/fibroblast interactions. Lab Chip. 2021;21:365-77.
52. Nikolaev M, Mitrofanova O, Broguiere N, et al. Homeostatic mini-intestines through scaffold-guided organoid morphogenesis. Nature. 2020;585:574-8.
53. Mitrofanova O, Nikolaev M, Xu Q, et al. Bioengineered human colon organoids with in vivo-like cellular complexity and function. Cell Stem Cell. 2024;31:1175-1186.e7.
54. Wang Y, Gunasekara DB, Reed MI, et al. A microengineered collagen scaffold for generating a polarized crypt-villus architecture of human small intestinal epithelium. Biomaterials. 2017;128:44-55.
55. Shin W, Wu A, Massidda MW, et al. A robust longitudinal co-culture of obligate anaerobic gut microbiome with human intestinal epithelium in an anoxic-oxic interface-on-a-chip. Front Bioeng Biotechnol. 2019;7:13.
56. Shin W, Kim HJ. Intestinal barrier dysfunction orchestrates the onset of inflammatory host-microbiome cross-talk in a human gut inflammation-on-a-chip. Proc Natl Acad Sci U S A. 2018;115:E10539-47.
57. Kim HJ, Li H, Collins JJ, Ingber DE. Contributions of microbiome and mechanical deformation to intestinal bacterial overgrowth and inflammation in a human gut-on-a-chip. Proc Natl Acad Sci U S A. 2016;113:E7-15.
58. Jalili-Firoozinezhad S, Gazzaniga FS, Calamari EL, et al. A complex human gut microbiome cultured in an anaerobic intestine-on-a-chip. Nat Biomed Eng. 2019;3:520-31.
59. Kim R, Wang Y, Sims CE, Allbritton NL. A Platform for co-culture of primary human colonic epithelium with anaerobic probiotic bacteria. Front Bioeng Biotechnol. 2022;10:890396.
60. Lee KW, Shin JS, Lee CM, et al. Gut-on-a-chip for the analysis of bacteria-bacteria interactions in gut microbial community: what would be needed for bacterial co-culture study to explore the diet-microbiota relationship? Nutrients. 2023;15:1131.
61. Delannoy E, Burette A, Janel S, et al. Gut-on-chip methodology based on 3D-printed molds: a cost-effective and accessible approach. Lab Chip. 2025;25:4396-409.
62. Ballerini M, Galiè S, Tyagi P, et al. A gut-on-a-chip incorporating human faecal samples and peristalsis predicts responses to immune checkpoint inhibitors for melanoma. Nat Biomed Eng. 2025;9:967-84.
63. Shah P, Fritz JV, Glaab E, et al. A microfluidics-based in vitro model of the gastrointestinal human-microbe interface. Nat Commun. 2016;7:11535.
64. Kasendra M, Luc R, Yin J, et al. Duodenum intestine-chip for preclinical drug assessment in a human relevant model. Elife. 2020:9.
65. Kasendra M, Tovaglieri A, Sontheimer-Phelps A, et al. Development of a primary human small intestine-on-a-chip using biopsy-derived organoids. Sci Rep. 2018;8:2871.
66. Moerkens R, Mooiweer J, Ramírez-Sánchez AD, et al. An iPSC-derived small intestine-on-chip with self-organizing epithelial, mesenchymal, and neural cells. Cell Rep. 2024;43:114247.
67. Eslami Amirabadi H, Donkers JM, Wierenga E, et al. Intestinal explant barrier chip: long-term intestinal absorption screening in a novel microphysiological system using tissue explants. Lab Chip. 2022;22:326-42.
68. Donkers JM, Wiese M, van den Broek TJ, et al. A host-microbial metabolite interaction gut-on-a-chip model of the adult human intestine demonstrates beneficial effects upon inulin treatment of gut microbiome. Microbiome Res Rep. 2024;3:18.
69. Zhu W, Zhang X, Wang D, Yao Q, Ma GL, Fan X. Simulator of the human intestinal microbial ecosystem (SHIME®): Current Developments, Applications, and Future Prospects. Pharmaceuticals (Basel). 2024;17:1639.
70. Maurer M, Gresnigt MS, Last A, et al. A three-dimensional immunocompetent intestine-on-chip model as in vitro platform for functional and microbial interaction studies. Biomaterials. 2019;220:119396.
71. Dakal TC, Xu C, Kumar A. Advanced computational tools, artificial intelligence and machine-learning approaches in gut microbiota and biomarker identification. Front Med Technol. 2024;6:1434799.
